Remove 2025 Remove Independent Pharmacies Remove Sterile Compounds
article thumbnail

Should Pharmacies Keep Compounding GLP1s?

DiversifyRx

Deadlines For Compounding GLP1s (Semaglutide & Tirzepatide) Stay up to date on the FDA’s opinion at their website HERE. 503As must stop compounding GLP1s as of April 24, 2025. While 503Bs must stop by May 22, 2025 Tirzepatide: Injunction denied. 503As must stop compounding GLP1s as of March 5, 2025.